²ÝÁñÉçÇøÈë¿Ú

Email

eberlin@bcm.edu

Positions

Professor of Surgery

Division of Surgical Oncology
²ÝÁñÉçÇøÈë¿Ú

Vice Chair for Research

Michael E. DeBakey Department of Surgery

Translational Research and Innovations Endowed Chair

²ÝÁñÉçÇøÈë¿Ú

Director, Translational and Innovations Research

Michael E. DeBakey Department of Surgery

Co-Director, INSTINCT

Michael E. DeBakey Department of Surgery

Interdisciplinary Surgical Technology and Innovation Center

Addresses

Alkek Building for Biomedical Research (Lab)

Room R414
Houston, TX 77030
United States

Education

BS from State University of Campinas

Campinas, São Paulo, Brazil

Chemistry

PhD from Purdue University

West Lafayette, Indiana

Analytical Chemistry

Research Fellowship at Stanford University

Stanford, California

Honors & Awards

Norman Hackerman Award in Chemical Research

The Welch Foundation

Nick Valvano Translational Research Grant

V Foundation for Cancer Research

Professional Interests

• Mass spectrometry
• Cancer diagnosis
• Medical devices

Professional Statement

Dr. Eberlin received a bachelor’s in chemistry from the State University of Campinas in Sao Paulo, Brazil, and a Ph.D. in analytical chemistry from Purdue University. She went on to complete a research fellowship in the Department of Chemistry at Stanford University in California. Prior to joining ²ÝÁñÉçÇøÈë¿Ú, Dr. Eberlin was an assistant professor in the Departments of Chemistry, Oncology and Diagnostic Medicine at The University of Texas at Austin.
Dr. Eberlin and her research team are the recipients of many honors and awards for their scientific research, including a NIH/NCI K99/R00 Pathway to Independence Award, a Forbes 30 under 30 listing in the ²ÝÁñÉçÇøÈë¿Ú category, a Moore Inventor Fellowship, and a MacArthur Fellowship in 2018. Her research group is funded by grants from the NIH, CPRIT and other research foundations. Additionally, Dr. Eberlin has published more than 80 peer-reviewed research articles in top-rated journals such as PNAS, Science Translational Medicine, Nature Communications, Cancer Research, and Clinical Chemistry.
Dr. Eberlin’s research program centers around the development and application of novel mass spectrometry technologies in health-related research, with a particular focus on disease detection and diagnosis to improve patient care and clinical outcomes.

Websites

Selected Publications

• M. E. King, J. Zhang, J. Q. Lin, K. Y. Garza, R. J. DeHoog, C. L. Feider, A. Bensussan, M. Sans, A. Krieger, S. Badal, M. F. Keating, S. Woody, S. Dhingra, W. Yu, C. Pirko, K. A. Brahmbhatt, G. Van Buren, W. E. Fisher, J. Suliburk, and L. S. Eberlin "." PNAS.;
• J. Zhang, M. Sans, R. J. DeHoog, K. Y. Garza, M. E. King, C. L. Feider, A. Bensussan, M. F. Keating, et al. "." Clinical Chemistry.;
• A. V. Bensussan, J. Lin, C. Guo, R. Katz, S. Krishnamurthy, E. Cressman, and L. S. Eberlin "." Clinical Chemistry.;
• M. F. Keating, J. Zhang, C. L. Feider, S. Retailleau, R. Reid, A. Antaris, B. Hart, G. Tan, T. E. Milner, K. Miller, and L. S. Eberlin "." Analytical Chemistry.;